Advanced Cell Technology To Present Progress Report on Product Development and ACTCellerate Platform at BIO Investor Forum
Thursday October 19, 8:41 am ET
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.'s (OTCBB:ACTC - News) Michael West, Ph.D., Chairman, President and Chief Scientific Officer will be presenting at the 2006 BIO Investor Forum at the Palace Hotel, in San Francisco, California on October 19, 2006. The presentation is scheduled for 2:20 PM in the Sea Cliff room. Presentation slides and a live web cast may be accessed through the company's website at
www.advancedcell.com.
Dr. West will discuss ACT's recently-published data on blastomere biopsy (a novel technique that allows human ES cell lines to be produced from a single embryonic cell), thereby demonstrating the feasibility of producing new human ES cell lines without disaggregating human embryos. In addition, Dr. West will discuss recently-published positive results in preclinical studies with the company's retinal pigment epithelial (RPE)cells, and an update on ACTCellerate. As previously announced by the company, ACTCellerate is a technology platform for isolating novel purified and scalable cell types from human embryonic stem cells. New results relating to novel propagating human heart progenitor and cranial neural crest cell lines isolated using the ACTCellerate technology will be presented.